Dr. Steven Wayne Sukin , MD
Urology • Tomball, TX
506 Graham Dr, Ste 150
Tomball, TX 773753366
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 5, 2006; this date does not establish years in practice.
-
Published CMS data list 5,850 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 81003 — Automated urinalysis test: 1,344 service units.
- 99214 — Established patient outpatient office visit: 996 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 991 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 32 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,274 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 880 prescription fills, including refills.
- Gemtesa (Vibegron) — 366 prescription fills, including refills.
- Finasteride — 337 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 27 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 80% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 4,607 in 2020 to 5,850 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
506 Graham Dr
Ste 150
Tomball, TX 773753366
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Texas Oncology Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Tufts University School Of Medicine
1996
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,081 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $561,123 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $424,517 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
6,577 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$393,029 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,818.79 across 39 records.
By nature of payment
- Food and Beverage: $1,818.79 across 39 records.
Reporting-company totals (3 largest of 14)
- Boston Scientific Corporation: $524.19 across 12 records.
- BIOPROTECT MEDICAL, INC.: $229.36 across 5 records.
- Teleflex LLC: $213.93 across 2 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
30 years (graduated 1996)
CMS Doctors and Clinicians data list 1996 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Sukin has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Sukin as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Tomball and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 80% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Too few clinicians listed under Urology in Tomball have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $130,907. Middle half: $56,287 to $242,595.
Too few clinicians listed under Urology in Tomball have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $98,400. Middle half: $41,252 to $185,944.
Too few clinicians listed under Urology in Tomball have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Too few clinicians listed under Urology in Tomball have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
Too few clinicians listed under Urology in Tomball have Medicare Part D data for 2024 to compare.
8 active clinicians are listed under Urology with a practice address in Tomball, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 27% from 4,607 in 2020 to 5,850 in 2024.
- 2020: 4,607
- 2021: 7,755
- 2022: 10,129
- 2023: 7,012
- 2024: 5,850
-
Medicare-allowed amount
Medicare-allowed amount decreased 17% from $678,256 in 2020 to $561,123 in 2024.
- 2020: $678,256
- 2021: $661,157
- 2022: $802,732
- 2023: $747,777
- 2024: $561,123
-
Paid by Medicare
Paid by Medicare decreased 19% from $524,583 in 2020 to $424,517 in 2024.
- 2020: $524,583
- 2021: $516,151
- 2022: $629,050
- 2023: $577,565
- 2024: $424,517
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 16% from 2,818 in 2020 to 3,274 in 2024.
- 2020: 2,818
- 2021: 2,788
- 2022: 2,985
- 2023: 2,977
- 2024: 3,274
-
30-day fills
30-day fills increased 25% from 5,242 in 2020 to 6,577 in 2024.
- 2020: 5,242
- 2021: 5,400
- 2022: 5,906
- 2023: 5,974
- 2024: 6,577
-
Part D drug cost
Part D drug cost increased 48% from $265,044 in 2020 to $393,029 in 2024.
- 2020: $265,044
- 2021: $280,257
- 2022: $351,460
- 2023: $298,254
- 2024: $393,029
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $367.00 in 2021 to $1,818.80 in 2025.
- 2021: $367.00
- 2022: $1,832.70
- 2023: $2,153.30
- 2024: $5,882.89
- 2025: $1,818.80
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 40 records totaling $1,818.80.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
UROLIFT | General | $181.71 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $149.82 |
| Agiliti Health, Inc. |
Food and Beverage
Cash or cash equivalent
|
Sonablate HIFU | General | $126.70 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $125.00 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $101.62 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $99.64 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $90.43 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $75.03 |
| BIOPROTECT MEDICAL, INC. |
Food and Beverage
In-kind items and services
|
BIOPROTECT BALLOON IMPLANT SYSTEM | General | $72.18 |
| Profound Medical Corp. |
Food and Beverage
Cash or cash equivalent
|
Tulsa-Pro | General | $65.94 |
| Profound Medical Corp. |
Food and Beverage
Cash or cash equivalent
|
Tulsa-Pro | General | $60.28 |
| BIOPROTECT MEDICAL, INC. |
Food and Beverage
In-kind items and services
|
BIOPROTECT BALLOON IMPLANT SYSTEM | General | $57.48 |
| BIOPROTECT MEDICAL, INC. |
Food and Beverage
In-kind items and services
|
BIOPROTECT BALLOON IMPLANT SYSTEM | General | $52.50 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $42.23 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $37.88 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
UROLIFT | General | $32.22 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $30.15 |
| BIOPROTECT MEDICAL, INC. |
Food and Beverage
In-kind items and services
|
BIOPROTECT BALLOON IMPLANT SYSTEM | General | $27.39 |
| Profound Medical Corp. |
Food and Beverage
Cash or cash equivalent
|
Tulsa-Pro | General | $27.39 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.00 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
Optilume BPH Drug Coated Balloon Catheter | General | $25.45 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Rezum Generator | General | $24.58 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.43 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
JATENZO | General | $23.09 |
| BLUEWIND MEDICAL |
Food and Beverage
In-kind items and services
|
REVI | General | $22.65 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
81003
Automated urinalysis test
|
1,344 | 861 | $16.00 | $2.16 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
996 | 696 | $368.00 | $121.80 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
991 | 728 | $35.00 | $15.85 |
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
798 | 19 | $249.37 | $55.85 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
242 | 242 | $565.00 | $159.99 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
240 | 35 | $3675.00 | $176.31 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
194 | 165 | $684.00 | $224.07 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
126 | 112 | $97.00 | $10.66 |
|
52442
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant
|
122 | 21 | $3366.00 | $777.52 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
100 | 61 | $247.00 | $75.23 |
|
J1580
Injection, garamycin, gentamicin, up to 80 mg
|
82 | 30 | $6.98 | $2.39 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
78 | 77 | $250.00 | $88.32 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
66 | 61 | $694.00 | $165.06 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
59 | 44 | $145.00 | $32.81 |
|
55700
Biopsy of prostate gland
|
48 | 48 | $775.00 | $226.31 |
|
76942
Ultrasonic guidance for needle placement
|
48 | 48 | $633.00 | $54.19 |
|
J1885
Injection, ketorolac tromethamine, per 15 mg
|
38 | 19 | $4.00 | $0.74 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
34 | 30 | $68.00 | $22.15 |
|
51700
Simple bladder irrigation and/or instillation
|
29 | 24 | $296.00 | $68.84 |
|
52441
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant
|
21 | 21 | $4403.00 | $1149.55 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
19 | 17 | $61.00 | $23.12 |
|
51729
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies
|
18 | 18 | $1205.00 | $360.14 |
|
51741
Electronic assessment of bladder emptying
|
18 | 18 | $277.00 | $6.80 |
|
51792
Assessment of muscle signal of pelvic nerves
|
18 | 18 | $747.00 | $127.96 |
|
51797
Insertion of device into abdomen with pressure and urine flow rate study
|
18 | 18 | $522.00 | $176.59 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 880 | 74,128 | $14,785.46 | 357 |
| Gemtesa | Vibegron | 366 | 13,584 | $211,183.08 | 93 |
| Finasteride | Finasteride | 337 | 30,128 | $5,671.62 | 137 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 281 | 1,572 | $1,072.60 | 240 |
| Tramadol Hcl | Tramadol Hcl | 164 | 515 | $225.69 | 149 |
| Myrbetriq | Mirabegron | 163 | 6,888 | $101,977.02 | 38 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 152 | 9,755 | $2,370.74 | 50 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 110 | 1,262 | $1,610.23 | 86 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 110 | 9,314 | $12,678.03 | 50 |
| Oxybutynin Chloride | Oxybutynin Chloride | 102 | 2,900 | $1,323.25 | 76 |
| Testosterone Cypionate | Testosterone Cypionate | 99 | 5,038 | $4,918.78 | 37 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 78 | 6,965 | $1,932.54 | 34 |
| Levofloxacin | Levofloxacin | 60 | 189 | $115.23 | 56 |
| Anastrozole | Anastrozole | 59 | 2,861 | $75.11 | 18 |
| Cefdinir | Cefdinir | 54 | 434 | $622.59 | 50 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 40 | 845 | $208.11 | 33 |
| Methenamine Hippurate | Methenamine Hippurate | 40 | 2,280 | $2,140.71 | — |
| Solifenacin Succinate | Solifenacin Succinate | 28 | 2,460 | $1,351.33 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 635 | $460.69 | 25 |
| Tadalafil | Tadalafil | 27 | 1,050 | $3,068.61 | — |
| Sildenafil Citrate | Sildenafil Citrate | 19 | 286 | $19.75 | — |
| Mirabegron Er | Mirabegron | 16 | 1,140 | $11,799.93 | — |
| Clindamycin Hcl | Clindamycin Hcl | 14 | 57 | $47.81 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | 1,082 | $268.40 | — |
| Xyosted | Testosterone Enanthate | 13 | 538 | $10,951.13 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20070207000031
TX
1759303993
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Texas Oncology Pa
7777 Forest Ln, Dallas, TX 752306855
Phone: 9725665400
Texas Oncology Pa
7777 Forest Ln, Dallas, TX 752306861
Phone: 9725663000
Texas Oncology Pa
7848 Gateway Blvd E, El Paso, TX 799151815
Phone: 9155991313
Texas Oncology Pa
13215 Dotson Rd, Houston, TX 770704543
Phone: 2815170808
Texas Oncology Pa
2026 S Jackson St, Jacksonville, TX 757665822
Phone: 9035862456
Texas Oncology Pa
506 Graham Dr, Tomball, TX 773753467
Phone: 2813515174
Texas Oncology Pa
17189 I 45, Shenandoah, TX 773853320
Phone: 2813515174
Texas Oncology Pa
925 Gessner Rd, Houston, TX 770242843
Phone: 7134671722
Texas Oncology Pa
Po Box, Dallas, TX 753911242
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified), MPAS
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Nurse Practitioner
Advanced Practice Registered Nurse
Career & Practice History
NPI enumerated January 05, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Tomball
- Dr. Penner Schraudenbach, MD
- Dr. Miguel Mercado, MD
- Dr. Clyde Corey, MD
- Dr. Liliana Woo, MD
- Dr. Matthew Hogan, MD
- Dr. Abimbola Ayangbesan, MD
Mailing Address
Po Box 911230
Dallas, TX 753911230
Phone: 9729978000